Cargando…
Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
Prostate specific antigen (PSA) is one of the best-known biomarkers for screening, diagnosis and follow-up of patients for prostate cancer. Owing to several inherent limitations with PSA, various newer blood and urinary based biomarkers have been evaluated in pursuit of better detection and risk str...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Sexual Medicine and Andrology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761236/ https://www.ncbi.nlm.nih.gov/pubmed/34983086 http://dx.doi.org/10.5534/wjmh.210076 |